PubMed

Expression of EpCAM in uveal melanoma.

Odashiro DN, Odashiro AN, Pereira PR, Godeiro K, Antecka E, Di Cesare S, Burnier MN Jr.

Cancer Cell Int. 2006 Nov 24;6:26.PMID: 17125516 [PubMed]Related articlesFree article

Expression of the metastasis suppressor gene KISS1 in uveal melanoma.

Martins CM, Fernandes BF, Antecka E, Di Cesare S, Mansure JJ, Marshall JC, Burnier MN Jr.

Eye (Lond). 2008 May;22(5):707-11. Epub 2008 Jan 25.PMID: 18219339 [PubMed - indexed for MEDLINE]Related articles

Expression of nm23-H1 in uveal melanoma.

Bakalian S, Marshall JC, Faingold D, Logan P, Antecka E, Burnier MN Jr.

Melanoma Res. 2007 Oct;17(5):284-90.PMID: 17885583 [PubMed - indexed for MEDLINE]Related articles

The role of c-kit and imatinib mesylate in uveal melanoma.

Pereira PR, Odashiro AN, Marshall JC, Correa ZM, Belfort R Jr, Burnier MN Jr.

J Carcinog. 2005 Oct 19;4:19.PMID: 16236162 [PubMed]Related articlesFree article

Catumaxomab: A bispecific trifunctional antibody.

Sebastian M, Kuemmel A, Schmidt M, Schmittel A.

Drugs Today (Barc). 2009 Aug;45(8):589-97.PMID: 19927225 [PubMed - in process]Related articles

Expression and prognostic significance of iNOS in uveal melanoma.

Johansson CC, Mougiakakos D, Trocme E, All-Ericsson C, Economou MA, Larsson O, Seregard S, Kiessling R.

Int J Cancer. 2009 Oct 21. [Epub ahead of print]PMID: 19847812 [PubMed - as supplied by publisher]Related articles

Expression of the SST receptor 2 in uveal melanoma is not a prognostic marker.

Kouch-el Filali M, Kilic E, Melis M, de Klein A, de Jong M, Luyten GP.

Graefes Arch Clin Exp Ophthalmol. 2008 Nov;246(11):1585-92. Epub 2008 Aug 6.PMID: 18682975 [PubMed - indexed for MEDLINE]Related articles

Immunomagnetic isolation and in vitro expansion of human uveal melanoma cell lines.

Cools-Lartigue JJ, McCauley CS, Marshall JC, Di Cesare S, Gregoire F, Antecka E, Logan P, Burnier MN.

Mol Vis. 2008 Jan 10;14:50-5.PMID: 18246031 [PubMed - indexed for MEDLINE]Related articlesFree article

Frequent EpCam protein expression in human carcinomas.

Went PT, Lugli A, Meier S, Bundi M, Mirlacher M, Sauter G, Dirnhofer S.

Hum Pathol. 2004 Jan;35(1):122-8.PMID: 14745734 [PubMed - indexed for MEDLINE]Related articles

Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy.

Yanamoto S, Kawasaki G, Yoshitomi I, Iwamoto T, Hirata K, Mizuno A.

Oral Oncol. 2007 Oct;43(9):869-77. Epub 2007 Jan 4.PMID: 17207659 [PubMed - indexed for MEDLINE]Related articles

Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion.

Sankpal NV, Willman MW, Fleming TP, Mayfield JD, Gillanders WE.

Cancer Res. 2009 Feb 1;69(3):753-7. Epub 2009 Jan 13.PMID: 19141643 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic significance of EpCAM expression in human esophageal cancer.

Kimura H, Kato H, Faried A, Sohda M, Nakajima M, Fukai Y, Miyazaki T, Masuda N, Fukuchi M, Kuwano H.

Int J Oncol. 2007 Jan;30(1):171-9.PMID: 17143526 [PubMed - indexed for MEDLINE]Related articles

Immunohistochemical expression of melan-A and tyrosinase in uveal melanoma.

Fernandes BF, Odashiro AN, Saraiva VS, Logan P, Antecka E, Burnier MN Jr.

J Carcinog. 2007 Apr 20;6:6.PMID: 17445277 [PubMed]Related articlesFree article

[What else can we do for uveal melanoma]

Li B, Xu XL.

Zhonghua Yan Ke Za Zhi. 2009 Apr;45(4):289-92. Chinese. PMID: 19575957 [PubMed - in process]Related articles

Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer.

Ruf P, Gires O, Jäger M, Fellinger K, Atz J, Lindhofer H.

Br J Cancer. 2007 Aug 6;97(3):315-21. Epub 2007 Jul 10.PMID: 17622246 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression profiling of formalin-fixed paraffin embedded primary human uveal melanomas using DASL matrices.

Di Cesare S, Nantel A, Marshall JC, Fernandes BF, Antecka E, Orellana ME, Abourbih D, Saornil AM, Burnier MN Jr.

J Cancer Res Clin Oncol. 2010 Apr;136(4):577-86. Epub 2009 Oct 13.PMID: 19823872 [PubMed - in process]Related articles

EpCAM homologues exhibit epithelial-specific but different expression patterns in the kidney.

Trzpis M, McLaughlin PM, Popa ER, Terpstra P, van Kooten TG, de Leij LM, Harmsen MC.

Transgenic Res. 2008 Apr;17(2):229-38. Epub 2007 Oct 17.PMID: 17940847 [PubMed - indexed for MEDLINE]Related articles

Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I/II study.

Burges A, Wimberger P, Kümper C, Gorbounova V, Sommer H, Schmalfeldt B, Pfisterer J, Lichinitser M, Makhson A, Moiseyenko V, Lahr A, Schulze E, Jäger M, Ströhlein MA, Heiss MM, Gottwald T, Lindhofer H, Kimmig R.

Clin Cancer Res. 2007 Jul 1;13(13):3899-905.PMID: 17606723 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma.

Lederman M, Meir T, Zeschnigk M, Pe'er J, Chowers I.

Curr Eye Res. 2008 Oct;33(10):876-84.PMID: 18853322 [PubMed - indexed for MEDLINE]Related articles

Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.

Deng G, Herrler M, Burgess D, Manna E, Krag D, Burke JF.

Breast Cancer Res. 2008;10(4):R69. Epub 2008 Aug 7.PMID: 18687126 [PubMed - indexed for MEDLINE]Related articlesFree article